Topic Podcasts - JAK TYK2 Save
ACR22 Year in Review Report
Deucravacitinib in PsA
JAK inhibitors in rheumatic diseases
JAK vs TNF inhibitor Infections in RA
New Treatments for SLE?
Prelude to a Meeting (ACR22) (11.11.2022)
Switching Between JAK Inhibiters in RA
Tapering Methotrexate with Biologics or JAK Inhibitors in RA
Tofacitinib and RA-ILD
Upadacitinib vs Adalimumab in PsA using RAPID3
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.